Rashtriya Chemicals And Fertil Share Price
Sector: Chemical Manufacturing
163.90 +0.60 (0.37%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
162.20
Today’s High
166.55
52 Week Low
108.05
52 Week High
245.00
163.95 +0.64 (0.39%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
162.20
Today’s High
166.50
52 Week Low
110.80
52 Week High
245.00
Key Metrics
- Market Cap (In Cr) 9042.17
- Beta 1.68
- Div. Yield (%) 0.81
- P/B 1.9
- TTM P/E 28.59
- Peg Ratio -1.25
- Sector P/E 17.82
- D/E 0.01
- Open Price 164.55
- Prev Close 163.3
Rashtriya Chemicals And Fertil Analysis
Price Analysis
-
1 Week1.87%
-
3 Months38.15%
-
6 Month-8.47%
-
YTD-6.04%
-
1 Year-2.85%
Risk Meter
- 46% Low risk
- 46% Moderate risk
- 46% Balanced Risk
- 46% High risk
- 46% Extreme risk
Rashtriya Chemicals And Fertil News
Q4 results today: LIC, Info Edge, Minda Corp, Supriya Lifesciences, Bosch, more
2 min read . 27 May 2025Top three fertilizer stocks to buy today, 21 April, recommended by Ankush Bajaj
6 min read . 21 Apr 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 25 Mar 2025Buy or sell: Vaishali Parekh recommends three stocks for today — Nov 29
2 min read . 29 Nov 2024Rashtriya Chemicals And Fertil Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 16933.64
- Selling/ General/ Admin Expenses Total
- 1490.13
- Depreciation/ Amortization
- 262.76
- Other Operating Expenses Total
- 644.39
- Total Operating Expense
- 16517.28
- Operating Income
- 416.36
- Net Income Before Taxes
- 328.32
- Net Income
- 242.45
- Diluted Normalized EPS
- 4.33
- Period
- 2025
- Total Assets
- 11266.63
- Total Liabilities
- 6521.3
- Total Equity
- 4745.33
- Tangible Book Valueper Share Common Eq
- 86
- Period
- 2025
- Cashfrom Operating Activities
- 2363.82
- Cashfrom Investing Activities
- -680.55
- Cashfrom Financing Activities
- -852.73
- Net Changein Cash
- 830.54
- Period
- 2024
- Total Revenue
- 16981.31
- Selling/ General/ Admin Expenses Total
- 1747.29
- Depreciation/ Amortization
- 228.24
- Other Operating Expenses Total
- 68.36
- Total Operating Expense
- 16600.08
- Operating Income
- 381.23
- Net Income Before Taxes
- 301.17
- Net Income
- 225.28
- Diluted Normalized EPS
- 3.63
- Period
- 2024
- Total Assets
- 11455.72
- Total Liabilities
- 6849.98
- Total Equity
- 4605.74
- Tangible Book Valueper Share Common Eq
- 83.48
- Period
- 2024
- Cashfrom Operating Activities
- -422.27
- Cashfrom Investing Activities
- -464.45
- Cashfrom Financing Activities
- 1031.91
- Net Changein Cash
- 145.19
- Period
- 2023
- Total Revenue
- 21451.54
- Selling/ General/ Admin Expenses Total
- 1715.19
- Depreciation/ Amortization
- 206.73
- Other Operating Expenses Total
- 91.7
- Total Operating Expense
- 19947.17
- Operating Income
- 1504.37
- Net Income Before Taxes
- 1273.14
- Net Income
- 966.31
- Diluted Normalized EPS
- 16.32
- Period
- 2023
- Total Assets
- 9704.62
- Total Liabilities
- 5114.5
- Total Equity
- 4590.12
- Tangible Book Valueper Share Common Eq
- 83.19
- Period
- 2023
- Cashfrom Operating Activities
- 787.01
- Cashfrom Investing Activities
- -315.53
- Cashfrom Financing Activities
- -1559.91
- Net Changein Cash
- -1088.43
- Period
- 2022
- Total Revenue
- 12812.17
- Selling/ General/ Admin Expenses Total
- 1557.18
- Depreciation/ Amortization
- 183.94
- Other Operating Expenses Total
- 90.96
- Total Operating Expense
- 11877.87
- Operating Income
- 934.3
- Net Income Before Taxes
- 941.94
- Net Income
- 702.39
- Diluted Normalized EPS
- 10.9
- Period
- 2022
- Total Assets
- 10530.82
- Total Liabilities
- 6648.95
- Total Equity
- 3881.87
- Tangible Book Valueper Share Common Eq
- 70.33
- Period
- 2022
- Cashfrom Operating Activities
- -592.09
- Cashfrom Investing Activities
- -378.67
- Cashfrom Financing Activities
- 599.26
- Net Changein Cash
- -371.5
- Period
- 2021
- Total Revenue
- 8281.18
- Selling/ General/ Admin Expenses Total
- 1436.66
- Depreciation/ Amortization
- 174.9
- Other Operating Expenses Total
- 25.48
- Total Operating Expense
- 7672.34
- Operating Income
- 608.84
- Net Income Before Taxes
- 518.36
- Net Income
- 375.3
- Diluted Normalized EPS
- 6.75
- Period
- 2021
- Total Assets
- 7621.14
- Total Liabilities
- 4287.71
- Total Equity
- 3333.43
- Tangible Book Valueper Share Common Eq
- 60.37
- Period
- 2021
- Cashfrom Operating Activities
- 5220.58
- Cashfrom Investing Activities
- -619.49
- Cashfrom Financing Activities
- -3131.17
- Net Changein Cash
- 1469.92
- Period
- 2020
- Total Revenue
- 9697.95
- Selling/ General/ Admin Expenses Total
- 1506.09
- Depreciation/ Amortization
- 168.67
- Other Operating Expenses Total
- 30.5
- Total Operating Expense
- 9342.35
- Operating Income
- 355.6
- Net Income Before Taxes
- 201.91
- Net Income
- 207.13
- Diluted Normalized EPS
- 5.02
- Period
- 2020
- Total Assets
- 10284.15
- Total Liabilities
- 7105.11
- Total Equity
- 3179.04
- Tangible Book Valueper Share Common Eq
- 57.58
- Period
- 2020
- Cashfrom Operating Activities
- -522.47
- Cashfrom Investing Activities
- -530.55
- Cashfrom Financing Activities
- 1051.93
- Net Changein Cash
- -1.09
- Period
- 2019
- Total Revenue
- 8885.47
- Selling/ General/ Admin Expenses Total
- 1455.54
- Depreciation/ Amortization
- 156.21
- Other Operating Expenses Total
- 56.25
- Total Operating Expense
- 8517.29
- Operating Income
- 368.18
- Net Income Before Taxes
- 230.16
- Net Income
- 134.08
- Diluted Normalized EPS
- 2.16
- Period
- 2019
- Total Assets
- 8915.44
- Total Liabilities
- 5885.79
- Total Equity
- 3029.65
- Tangible Book Valueper Share Common Eq
- 54.9
- Period
- 2019
- Cashfrom Operating Activities
- -1636.43
- Cashfrom Investing Activities
- -310.28
- Cashfrom Financing Activities
- 1945.06
- Net Changein Cash
- -1.65
- Period
- 2025-03-31
- Total Revenue
- 3729.67
- Selling/ General/ Admin Expenses Total
- 364.21
- Depreciation/ Amortization
- 78.18
- Other Operating Expenses Total
- 158.06
- Total Operating Expense
- 3624.99
- Operating Income
- 104.68
- Net Income Before Taxes
- 100.33
- Net Income
- 72.46
- Diluted Normalized EPS
- 1.25
- Period
- 2025-03-31
- Total Assets
- 11266.63
- Total Liabilities
- 6521.3
- Total Equity
- 4745.33
- Tangible Book Valueper Share Common Eq
- 86
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 2363.82
- Cashfrom Investing Activities
- -680.55
- Cashfrom Financing Activities
- -852.73
- Net Changein Cash
- 830.54
- Period
- 2024-12-31
- Total Revenue
- 4518.35
- Selling/ General/ Admin Expenses Total
- 408.11
- Depreciation/ Amortization
- 63.2
- Other Operating Expenses Total
- 146.27
- Total Operating Expense
- 4402.66
- Operating Income
- 115.69
- Net Income Before Taxes
- 105.29
- Net Income
- 80.23
- Diluted Normalized EPS
- 1.45
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 4289.56
- Selling/ General/ Admin Expenses Total
- 374.65
- Depreciation/ Amortization
- 61.62
- Other Operating Expenses Total
- 167.39
- Total Operating Expense
- 4149.67
- Operating Income
- 139.89
- Net Income Before Taxes
- 106.36
- Net Income
- 78.96
- Diluted Normalized EPS
- 1.43
- Period
- 2024-09-30
- Total Assets
- 12004.98
- Total Liabilities
- 7383.17
- Total Equity
- 4621.81
- Tangible Book Valueper Share Common Eq
- 83.77
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 2614.65
- Cashfrom Investing Activities
- -349.46
- Cashfrom Financing Activities
- -668.13
- Net Changein Cash
- 1597.06
- Period
- 2024-06-30
- Total Revenue
- 4396.06
- Selling/ General/ Admin Expenses Total
- 343.16
- Depreciation/ Amortization
- 59.76
- Other Operating Expenses Total
- 172.66
- Total Operating Expense
- 4339.95
- Operating Income
- 56.11
- Net Income Before Taxes
- 16.34
- Net Income
- 10.8
- Diluted Normalized EPS
- 0.2
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 3879.65
- Selling/ General/ Admin Expenses Total
- 310.02
- Depreciation/ Amortization
- 64.46
- Other Operating Expenses Total
- 186.25
- Total Operating Expense
- 3733.71
- Operating Income
- 145.94
- Net Income Before Taxes
- 120.03
- Net Income
- 95.24
- Diluted Normalized EPS
- 1.5
- Period
- 2024-03-31
- Total Assets
- 11455.72
- Total Liabilities
- 6849.98
- Total Equity
- 4605.74
- Tangible Book Valueper Share Common Eq
- 83.48
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -422.27
- Cashfrom Investing Activities
- -464.45
- Cashfrom Financing Activities
- 1031.91
- Net Changein Cash
- 145.19
- Period
- 2023-12-31
- Total Revenue
- 4903.52
- Selling/ General/ Admin Expenses Total
- 399.74
- Depreciation/ Amortization
- 56.49
- Other Operating Expenses Total
- 199.27
- Total Operating Expense
- 4875.92
- Operating Income
- 27.6
- Net Income Before Taxes
- 17.25
- Net Income
- 11.22
- Diluted Normalized EPS
- 0.2
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Rashtriya Chemicals And Fertil Technical
Moving Average
SMA
- 5 Day161.82
- 10 Day157.08
- 20 Day153.35
- 50 Day141.1
- 100 Day141.24
- 300 Day159.28
Rashtriya Chemicals And Fertil Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Sudarshan Chemicals Industries
- 1253.4
- -8.75
- -0.69
- 1312.45
- 782.4
- 9848.33
- Acutaas Chemicals
- 1104.45
- -17.8
- -1.59
- 1321.75
- 600
- 9036.78
- Rashtriya Chemicals And Fertil
- 163.9
- 0.6
- 0.37
- 245
- 108.05
- 9042.17
- Privi Speciality Chemicals
- 2260
- -30
- -1.31
- 2580
- 1138.7
- 8823.58
- Galaxy Surfactants
- 2451.5
- -7.45
- -0.3
- 3366.3
- 2025
- 8670.4
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Sudarshan Chemicals Industries
- 79.93
- 7.74
- 21.18
- 7.71
- Acutaas Chemicals
- 56.44
- 6.99
- 15.4
- 13.08
- Rashtriya Chemicals And Fertil
- 37.88
- 1.91
- 12.33
- 3.29
- Privi Speciality Chemicals
- 48.11
- 8.15
- 12.5
- 6.33
- Galaxy Surfactants
- 28.1
- 3.63
- 17.94
- 8.19
Rashtriya Chemicals And Fertil Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 27-May-25
- Audited Results & Final Dividend
- 12-Feb-25
- Quarterly Results
- 13-Nov-24
- Quarterly Results
- 12-Aug-24
- Quarterly Results
- 06-Jun-24
- Consolidated Audited Results
- 17-May-24
- Audited Results & Final Dividend
- 13-Feb-24
- Quarterly Results
- 10-Nov-23
- Quarterly Results
- 09-Nov-23
- Quarterly Results
- 11-Aug-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 30-Sept-24
- 13-Sept-24
- AGM
- 20-Dec-23
- 24-Nov-23
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 27-May-25
- -
- -
- 1.32
- 17-May-24
- 23-Sept-24
- 23-Sept-24
- 1.24
- 30-May-23
- 13-Dec-23
- 13-Dec-23
- 3.7
- 27-May-22
- 16-Dec-22
- 15-Dec-22
- 2.5
- 29-Nov-22
- 16-Dec-22
- 15-Dec-22
- 1.6
- 10-Nov-21
- 25-Nov-21
- 24-Nov-21
- 1.35
- 27-May-21
- 21-Oct-21
- 20-Oct-21
- 1.78
- 05-Feb-21
- 19-Feb-21
- 17-Feb-21
- 1.2


